The average 1-year price target for Walgreens Boots Alliance, Inc. The rating was maintained by Loop Capital with "Buy" on Thursday, October 26. They set a "buy" rating and a $95.00 price target for the company.
Walgreens Boots Alliance announced that its board has authorized a share buyback program on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares.
Following a public tender process, Walgreens Boots Alliance's bid met all the requirements set by the seller to acquire a 40% minority stake in GuoDa through a capital increase worth about $416 million. (Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell). (NasdaqGS:WBA) has a price to book ratio of 2.548570. (NASDAQ:WBA) on Thursday, October 29 with "Buy" rating. The overall volume in the last trading session was 5.97 million shares. (NASDAQ:WBA) on Thursday, September 1 with "Outperform" rating. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance, Inc.'s Return on Equity (ROE) is 13.90%, measure their profitability and reveals how much profit they generate with the money their shareholders. The company's quarterly revenue was up 5.3% compared to the same quarter a year ago. The other 15, though not evenly; between analysts who think you should buy Walgreens Boots Alliance, Inc. versus those who think you should sell it. WBA's financial leverage ratio is 1.36, which indicates that the company's asset base is primarily funded by equity capital. This buyback authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company's management believes its stock is undervalued. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.50 dividend on an annualized basis and a yield of 1.81%. "We have had a presence in China for around 10 years, initially through Alliance Boots, and we are excited about the opportunity to further invest in the country's fast growing retail pharmacy sector". The firm has price to earnings growth of 1.21, which is a valuation metric for determining relative trade-off among price of a stock. Following the completion of the transaction, the director now owns 50,000 shares of the company's stock, valued at $3,350,000. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. (CMG) stock price surged with Upswing change of 8.08% when it was compared to 20-day moving average. WBA's profit would be $1.25 billion giving it 13.92 P/E if the $1.26 EPS is correct. The disclosure for this purchase can be found here. Insiders own 14.80% of the company's stock. AXA lifted its position in shares of Walgreens Boots Alliance by 12.4% in the 3rd quarter. As per Monday, August 24, the company rating was downgraded by Zacks. Commonwealth Bank of Australia increased its holdings in shares of Walgreens Boots Alliance by 139.5% during the 2nd quarter.
The stock showed weekly performance of 4.56%, which was maintained for the month at 5.67%.Читайте также: Scranton veteran who was at Pearl Harbor recalls attack
Walgreens Boots Alliance (WBA) now has a 14-day Commodity Channel Index (CCI) of -56.90. While talking about Performance of the Stock, Walgreens Boots Alliance, Inc. now has a Weekly performance of -2.85%, monthly performance percentage is 4.95 percent, Quarterly performance is -14.16 percent, 6 months performance shows a percent value of -13.85% and Yearly Performance is -17.44 percent. The institutional investor owned 251,710 shares of the pharmacy operator's stock after selling 761,843 shares during the quarter.
The good news is there's still room for Walgreens Boots Alliance, Inc. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. & worldwide copyright and trademark laws.
The company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Soap & Glory, Liz Earle, Sleek MakeUP and Botanics.
The company said it has reached an agreement with China National Accord Medicines Corporation Ltd.to become an investor in its subsidiary, Sinopharm Holding Guoda Drugstores Co., Ltd., which operates and franchises retail pharmacies across China.При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2017 Copyright.
Автоматизированное извлечение информации сайта запрещено.
Код для вставки в блог